Your Trusted Partner for Pharmacovigilance Support in Algeria
Algeria represents one of North Africa’s most significant pharmaceutical markets, driven by increasing healthcare investments and a growing focus on patient safety. However, market entry and sustained operations in Algeria require more than product approval, they demand a well-defined, locally compliant pharmacovigilance system aligned with national expectations.
With a centralized pharmacovigilance authority and clearly defined responsibilities for Marketing Authorization Holders (MAHs), Algeria has established a structured framework for drug safety. For pharmaceutical companies, this translates into mandatory local representation, system documentation, and continuous safety monitoring obligations.
At DDReg, we deliver end-to-end pharmacovigilance services in Algeria, helping companies ensure compliance, maintain patient safety, and navigate regulatory complexity with confidence.
Pharmacovigilance Framework in Algeria
Pharmacovigilance in Algeria is governed by the Centre National de Pharmacovigilance et de Matériovigilance (CNPM), operating under the Ministry of Health, Population, and Hospital Reform (MSPRH).
The CNPM is responsible for:
- Monitoring adverse drug reactions (ADRs)
- Managing the national pharmacovigilance database
- Evaluating safety signals and implementing risk minimization measures
- Conducting inspections and ensuring compliance
Algeria’s pharmacovigilance system is centralized, requiring strong coordination between MAHs and national authorities.
Normative Framework Governing Pharmacovigilance in Algeria
Pharmacovigilance obligations are defined through national guidance and regulatory expectations:
- Algerian Guide on Pharmacovigilance (2019) – Core regulatory document outlining PV system requirements, stakeholder roles, and compliance obligations
- National regulatory directives issued by the Ministry of Health
- Alignment with international pharmacovigilance principles (WHO frameworks and best practices)
The 2019 guide provides detailed direction on:
- Adverse event reporting procedures
- Periodic Safety Update Reports (PSURs)
- Risk Management Plans (RMPs)
- Signal detection and evaluation
- Pharmacovigilance inspections and audits
This makes structured system implementation and documentation critical for compliance.
Local Pharmacovigilance Requirements in Algeria
Algeria places strong emphasis on local accountability and system transparency. Key Requirements:
Responsible Person for Pharmacovigilance (RPV)
- MAHs must appoint a Responsible Person for Pharmacovigilance (RPV)
- The RPV must reside in Algeria or be supported by a local pharmacovigilance contact person
- Acts as the primary liaison with CNPM
- Responsible for ADR reporting and compliance oversight
Pharmacovigilance System Master File (PSMF)
- Mandatory maintenance of a PSMF
-
Must document the entire pharmacovigilance system, including:
- SOPs and workflows
- Roles and responsibilities
- Safety data handling processes
- Must be readily available for CNPM inspection
These requirements make local presence and system readiness essential for regulatory compliance.
Our Pharmacovigilance Services in Algeria
DDReg provides comprehensive, scalable, and inspection-ready drug safety services in Algeria, ensuring compliance with CNPM requirements and global pharmacovigilance standards.
-
Individual Case Safety Report (ICSR) Management
-
Aggregate Reporting & Safety Writing
-
Signal Detection & Risk Management
-
Local Pharmacovigilance Compliance in Algeria
-
Literature Screening & Safety Intelligence
-
Pharmacovigilance Consulting Services in Algeria
Why Choose DDReg as Your Pharmacovigilance Company in Algeria?
We understand CNPM requirements, Algerian PV guidelines, and local regulatory expectations.
Our pharmacovigilance systems align with WHO and international best practices while ensuring local compliance.
We manage pharmacovigilance across the entire product lifecycle—from clinical development to post-marketing surveillance.
We ensure your PV system is always prepared for CNPM audits and inspections.
Advanced safety databases and automation tools enhance accuracy, compliance, and traceability.
Global Reach Explorer
Find Your Solution
Our Pharmacovigilance (PV) Services Expertise
ICSR Case Processing and Submission
Our advanced Individual Case Safety Report (ICSR) Pharmacovigilance Services are dedicated to ensuring patient safety through precise case handling....
Literature Monitoring
DDReg’s Literature Monitoring Services offer advanced pharmacovigilance literature screening for drug safety. We help Marketing...
Risk Management
Our expert risk management solutions ensure patient safety by proactively addressing potential hazards in pharmaceutical...
Audit and Compliance
Our specialized services ensure that pharmacovigilance systems across the drug development pipeline meet strict regulatory...
Pharmacovigilance Signal Management Services
DDReg’s specialized pharmacovigilance services ensure that potential adverse events are identified and addressed promptly...
QPPV Services
DDReg’s expert team provides comprehensive QPPV services designed to strengthen your pharmacovigilance system. We ensure that...
